Transcript Curriculum Vitae of EMILIA COCOROCCHIO

EMILIA COCOROCCHIO
Oncology, Istituto Europeo di Oncologia
SciVal Experts URL: http://www.experts.scival.com/moh-it/expert.asp?n=EMILIA+COCOROCCHIO&u_id=11561
26 Publications
2015
2014
2014
2013
2013
P.F. Ferrucci; S. Gandini; A. Battaglia; S. Alfieri; A.M. Di Giacomo; D. Giannarelli; G. C. Antonini
Cappellini; F. De Galitiis; P. Marchetti; G. Amato; A. Lazzeri; L. Pala; E. Cocorocchio; C. Martinoli
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated
metastatic melanoma patients
British Journal of Cancer. 2015;112(12):1904-1910. Vanna Chiarion Sileni; Jacopo Pigozzo; Paolo Antonio Ascierto; Antonio Maria Grimaldi; Michele Maio;
Lorenza Di Guardo; Paolo Marchetti; Francesco De Rosa; Carmen Nuzzo; Alessandro Testori; Emilia
Cocorocchio; Maria Grazia Bernengo; Michele Guida; Riccardo Marconcini; Barbara Merelli; Giorgio
Parmiani; Gaetana Rinaldi; Massimo Aglietta; Marco Grosso; Paola Queirolo
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma
treated at Italian centres through the expanded access programme
Journal of Experimental and Clinical Cancer Research. 2014;33(1). Giulio Tosti; Emilia Cocorocchio; Elisabetta Pennacchioli; Pier Francesco Ferrucci; Alessandro Testori;
Chiara Martinoli
Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target
therapies and immunomodulating agents
Expert Opinion on Biological Therapy. 2014;14(7):955-967. Fausto Maffini; Emilia Cocorocchio; Giancarlo Pruneri; Guido Bonomo; Fedro Peccatori; Laura
Chiapparini; Silvia Di Vincenzo; Giovanni Martinelli; Giuseppe Viale
Locked-in syndrome after basilary artery thrombosis by mucormycosis masquerading as
meningoencephalitis in a lymphoma patient
ecancermedicalscience. 2013;7(1). Sara Gandini; Esther De Vries; Giulio Tosti; Edoardo Botteri; Giuseppe Spadola; Patrick Maisonneuve;
Chiara Martinoli; Arjen Joosse; Pier Francesco Ferrucci; Federica Baldini; Emilia Cocorocchio; Elisabetta
Pennacchioli; Francesco Cataldo; Barbara Bazolli; Alessandra Clerici; Massimo Barberis; Veronique
Bataille; Alessandro Testori
Sunny holidays before and after melanoma diagnosis are respectively associated with lower
breslow thickness and lower relapse rates in Italy
PLoS ONE. 2013;8(11). 2013
Giulio Tosti; Emilia Cocorocchio; Elisabetta Pennacchioli
Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
Clinical, Cosmetic and Investigational Dermatology. 2013;6:245-256. 2013
E. Cocorocchio; F. Peccatori; A. Vanazzi; G. Piperno; L. Calabrese; E. Botteri; L. Travaini; L. Preda; G.
Martinelli
High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: A
reappraisal of prognostic factors
Hematological Oncology. 2013;31(1):34-40. 2013
2011
2011
2010
2008
2004
2004
2003
2003
2001
Silvia Bolis; Emilia Cocorocchio; Consuelo Corti; Andrés J.M. Ferreri; Niccolò Frungillo; Giovanni Grillo;
Emanuela Salè Omodeo; Lucilla Tedeschi; Vittorio Ruggero Zilioli
Clinical implications, safety, efficacy of recombinant human granulocyte colony-stimulating
factors and pegylated equivalent
Epidemiology Biostatistics and Public Health. 2013;10(4). Kamal S. Saini; Hatem A. Azim; Emilia Cocorocchio; Anna Vanazzi; Monika Lamba Saini; Paola Rafaniello
Raviele; Giancarlo Pruneri; Fedro A. Peccatori
Rituximab in Hodgkin lymphoma: Is the target always a hit?
Cancer Treatment Reviews. 2011;37(5):385-390. Emad Shash; Simona Bassi; Emilia Cocorocchio; Giovanni Maria Colpi; Saverio Cinieri; Fedro Alessandro
Peccatori
Fatherhood during imatinib
Acta Oncologica. 2011;50(5):734-735. E. Cocorocchio; A. Vanazzi; S. Bassi; F. Peccatori; P. Antoniotti; F. Gigli; L. Travaini; G. Piperno; G.
Pruneri; L. Preda; R. Biffi; E. Botteri; M. Negri; G. Martinelli
Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced
Hodgkin lymphoma
ecancermedicalscience. 2010;4(1):[184]. Hatem A. Azim Jr.; Giancarlo Pruneri; Emilia Cocorocchio; Saverio Cinieri; Paola R. Raviele; Simona
Bassi; Lorenzo Preda; Giovanni Martinelli; Fedro A. Peccatori
Rituximab in lymphocyte-predominant Hodgkin disease
Oncology. 2008;76(1):26-29. Pier Francesco Ferrucci; Cristina Rabascio; Chiara Mazzetta; Emilia Cocorocchio; Alberto Agazzi; Anna
Vanazzi; Saverio Cinieri; Fedro A. Peccatori; Mara Paolucci; Francesco Bertolini; Giovanni Martinelli
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis
in women with high-risk breast cancer
Clinical Cancer Research. 2004;10(18 I):6039-6046. G. Martinelli; E. Cocorocchio; F. Peccatori; E. Zucca; P.C. Saletti; L. Calabrese; R. Pastano; G. Pruneri; C.
Mazzetta; M. Ghielmini; F. Cavalli
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's
lymphoma: A retrospective analysis
British Journal of Haematology. 2004;125(5):584-589. Giovanni Martinelli; E. Cocorocchio; P.C. Saletti; R. Orecchia; J. Bernier; N. Tradati; P. Santoro; C.
Robertson; F.A. Peccatori; E. Zucca; F. Cavalli
Efficacy of vinblastine, bleomycin, methotrexate (VBM) combination chemotherapy with
involved field radiotherapy in early stage (I-IIA) Hodgkin disease patients
Leukemia and Lymphoma. 2003;44(11):1919-1923. P. Santoro; Giovanni Martinelli; P.F. Ferrucci; W. Mingrone; E. Cocorocchio; A. Conconi; F.A. Peccatori;
K. De Luzio; C. Mazzetta; E. Zucca; F. Cavalli
ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's
lymphoma
Leukemia and Lymphoma. 2003;44(5):801-806. F. Bertolini; W. Mingrone; A. Alietti; P.F. Ferrucci; E. Cocorocchio; F. Peccatori; S. Cineri; P. Mancuso; C.
Corsini; A. Burlini; E. Zucca; G. Martinelli
Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of
2001
2000
2000
2000
1999
1999
1999
1998
1998
clinical results and of surrogate angiogenesis markers
Annals of Oncology. 2001;12(7):987-990. F. Bertolini; W. Mingrone; A. Alietti; P.F. Ferrucci; E. Cocorocchio; F. Peccatori; S. Cinieri; P. Mancuso; C.
Corsini; A. Burlini; E. Zucca; G. Martinelli
Erratum: Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis.
Analysis of clinical results and of surrogate angiogenesis markers (Annals of Oncology
(2001) vol. 12 (7) (987-990))
Annals of Oncology. 2001;12(9):1333. C. Corsini; M. Ghielmini; P. Mancuso; F. Tealdo; M. Paolucci; M. Zucchetti; P.F. Ferrucci; E. Cocorocchio;
M. Mezzetti; A. Mori; M. Riggi; M. D'Incalci; G. Martinelli
Idarubicinol myelotoxicity: A comparison of in vitro data with clinical outcome in patients
treated with high-dose idarubicin
British Journal of Cancer. 2000;82(3):524-528. P.F. Ferrucci; A. Martinoni; E. Cocorocchio; M. Civelli; S. Cinieri; D. Cardinale; F.A. Peccatori; G.
Lamantia; A. Agazzi; C. Corsini; F. Tealdo; C. Florentini; C.M. Cipolla; G. Martinelli
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell
reinfusion in patients undergoing high-dose chemotherapy
Bone Marrow Transplantation. 2000;25(2):173-177. E. Gunsilius; A.L. Petzer; G. Gastl; F. Bertolini; M. Paolucci; F. Peccatori; S. Cinieri; A. Agazzi; P.F.
Ferrucci; E. Cocorocchio; A. Goldhirsch; G. Martinelli
Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma [3] (multiple letters)
British Journal of Haematology. 2000;108(3):661-663. Saverio Cinieri; L. Orlando; E. Cocorocchio; E. Munzone; C. Catania; C. Brunetti; A. Rocca; G. Martinelli;
F. Nolè
Profilassi della tossicità sul sistema venoso periferico associata alla somministrazione
endovenosa di vinorelbine
Clinica Terapeutica. 1999;150(3):225-229. R. Biffi; G. Martinelli; S. Pozzi; S. Cinieri; E. Cocorocchio; F. Peccatori; Pf Ferrucci; R. Pistorio; B.
Andreoni
Totally implantable central venous access ports for high-dose chemotherapy administration
and autologous stem cell transplantation: Analysis of overall and septic complications in 68
cases using a single type of device
Bone Marrow Transplantation. 1999;24(1):89-93. Francesco Bertolini; Mara Paolucci; Fedro Peccatori; Saverio Cinieri; Alberto Agazzi; Pier Francesco
Ferrucci; Emilia Cocorocchio; Aron Goldhirsch; Giovanni Martinelli
Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma
British Journal of Haematology. 1999;106(2):504-509. F. Bertolini; A. Lanza; F. Peccatori; C. Zibera; N. Gibelli; C. Perotti; G.A. Da Prada; L. Torretta; E.
Cocorocchio; G. Martinelli; G. Robustelli Della Cuna
Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer
patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or
G-CSF alone for mobilization
Annals of Oncology. 1998;9(8):913-916. C. Corsini; P. Mancuso; M. Ghielmini; M. Zucchetti; F. Tealdo; E. Cocorocchio; P.F. Ferrucci; F. Peccatori;
M. D'Lncalci; G. Martinelli
Inhibition of cfu-gm growth by idarubicinol containing plasma samples obtained from poor
prognosis lymphoma patients treated with 3-days infusion idarubicin
Experimental Hematology. 1998;26(8):785. © 2016 Elsevier B.V All rights reserved. SciVal ® is a registered trademark of Elsevier Properties SA | About SciVal Experts | Terms and
conditions | Privacy statement | Contact